Thyroid Nodule Gene Sequencing in a Danish Population
1 other identifier
interventional
30
1 country
1
Brief Summary
This pilot study aims at describing the prevalence and distribution of molecular alterations in thyroid nodules of benign and malignant origin at the level of DNA and RNA in a Danish population. Patients with thyroid nodules suspected of malignancy is included prospectively. Tissue samples are collected for molecular analyses form surgical specimens and bloodsamples, and preoperative clincial features are registered.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2022
CompletedFirst Submitted
Initial submission to the registry
March 15, 2022
CompletedFirst Posted
Study publicly available on registry
May 17, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 18, 2027
ExpectedJanuary 6, 2025
January 1, 2025
3.5 years
March 15, 2022
January 3, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
DNA alterations
Whole genome sequencing by next generation sequencing
Two years
RNA alterations
Total RNA sequencing including circular RNA, micro RNA and messenger RNA
Two years
DNA methylation
Whole Genome Bisulfite Sequencing
Two years
Circulating tumor DNA
Whole genome sequencing of leucocyt DNA and circularing DNA
Two years
Study Arms (1)
Molecular testing
EXPERIMENTALDescriptive and explorative study including identical molecular analyses applied to all included patients
Interventions
Collect thyroid tissue for molecular analysis from the histological specimen collected by routine surgery
Eligibility Criteria
You may qualify if:
- Thyroid nodule \>1.5 cm
- BSRTC: IV, V, og VI
You may not qualify if:
- No surgical specimen available
- Purely cystic nodules
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aarhus University Hospitallead
- University of Aarhuscollaborator
- Odense University Hospitalcollaborator
Study Sites (1)
Aarhus Universityhospital
Aarhus N, 8200, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kristine Z Swan
Aarhus University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
March 15, 2022
First Posted
May 17, 2022
Study Start
March 1, 2022
Primary Completion
August 31, 2025
Study Completion (Estimated)
January 18, 2027
Last Updated
January 6, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share
IPD will be in accordance with Danish legislation and regulations within the area